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A Rab5 endosomal pathway mediates
Parkin-dependent mitochondrial clearance
Babette C. Hammerling1,*, Rita H. Najor1,*, Melissa Q. Cortez1,*, Sarah E. Shires1, Leonardo J. Leon1,
Eileen R. Gonzalez1, Daniela Boassa2, Se´bastien Phan2, Andrea Thor2, Rebecca E. Jimenez1, Hong Li3,
Richard N. Kitsis4, Gerald W. Dorn II5, Junichi Sadoshima3, Mark H. Ellisman2 & Åsa B. Gustafsson1
Damaged mitochondria pose a lethal threat to cells that necessitates their prompt removal.
The currently recognized mechanism for disposal of mitochondria is autophagy, where
damaged organelles are marked for disposal via ubiquitylation by Parkin. Here we report a
novel pathway for mitochondrial elimination, in which these organelles undergo Parkin-
dependent sequestration into Rab5-positive early endosomes via the ESCRT machinery.
Following maturation, these endosomes deliver mitochondria to lysosomes for degradation.
Although this endosomal pathway is activated by stressors that also activate mitochondrial
autophagy, endosomal-mediated mitochondrial clearance is initiated before autophagy. The
autophagy protein Beclin1 regulates activation of Rab5 and endosomal-mediated degradation
of mitochondria, suggesting cross-talk between these two pathways. Abrogation of Rab5
function and the endosomal pathway results in the accumulation of stressed mitochondria
and increases susceptibility to cell death in embryonic ﬁbroblasts and cardiac myocytes.
These data reveal a new mechanism for mitochondrial quality control mediated by Rab5 and
early endosomes.
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M
itochondria are critical for many cellular functions,
including energy production, metabolism and cell
death. Therefore, maintaining a functional population
of mitochondria is critical for the survival of many cells.
Mitochondrial dysfunction is implicated in multiple neurodegen-
erative and cardiovascular diseases. To ensure maintenance of a
healthy mitochondrial network, impaired mitochondria are
selectively degraded by a process known as autophagy. Conven-
tional autophagy, which requires autophagy-related proteins
(Atg), such as Atg5 and Atg7 (refs 1,2), is well-known to play a
role in mitochondrial autophagy or mitophagy3. Recent studies
have also described the existence of an alternative pathway
of autophagy that is independent of Atg5/7 but dependent on
Unc-51-like autophagy activating kinase 1 (Ulk1) and Rab9
(ref. 4). There is also evidence that mitochondria can be directly
taken up into lysosomes via a process known as microautophagy5.
Whether additional pathways exist to clear mitochondria is
currently unknown.
The E3 ubiquitin ligase Parkin labels mitochondria for
autophagic degradation. Loss-of-function mutations in Parkin
contribute to loss of dopaminergic neurons in the substantia nigra
and cause early on-set of Parkinson’s disease6. Parkin also plays
an important role in clearing damaged mitochondria in the
myocardium and in promoting mitophagy of fetal cardiac
mitochondria in newborn mice7–10. Parkin is cytosolic under
baseline conditions, but rapidly translocates to depolarized
mitochondria where it ubiquitinates several different proteins11.
Interestingly, although ubiquitin can target proteins for
degradation via either the autophagic or endocytic pathways,
the relationship between Parkin-mediated ubiquitination and
the endosomal degradation pathway has not been explored.
Despite our growing knowledge of the molecules and pathways
involved in mitochondrial clearance, it is still unclear whether
autophagy is the only pathway by which cells can eliminate
mitochondria.
Here we describe a new mechanism of Parkin-mediated
mitochondrial clearance in cells that involves the small GTPase
Rab5 and the endosomal degradation pathway. We report
that mitochondria are sequestered inside Rab5-positive early
endosomes via the endosomal sorting complexes required for
transport (ESCRT) machinery and subsequently delivered to
lysosomes for degradation. Our data also demonstrate that
clearing dysfunctional mitochondria via the endosomal pathway
protects against cell death.
Results
Parkin directs autophagy-independent mitochondrial clearance.
Recent studies indicate that alternative pathways to traditional
autophagy exist that can clear unwanted entire organelles
including mitochondria. For instance, autophagy-deﬁcient
erythrocytes are still able to eliminate all their organelles
including mitochondria during maturation4. In addition, during
late embryogenesis, epithelial cells covering the anterior surface of
the lens differentiate into organelle-free transparent ﬁbre cells
during embryogenesis and autophagy-deﬁcient mice are still able
to generate normal lens ﬁbres without organelles12. To investigate
whether Parkin-mediated mitochondrial clearance was altered
in autophagy-deﬁcient cells, we used embryonic ﬁbroblasts
from Atg5 knockout mice (Atg5 / MEFs) and their control
littermates (wild-type mouse embryonic ﬁbroblasts (WT
MEFs))2. Consistent with previous studies, treatment of cells
with the mitochondrial uncoupler triﬂuoromethoxy carbonyl
cyanide phenylhydrazone (FCCP), led to formation of autopha-
gosomes in WT but not Atg5 / MEFs (Supplementary
Fig. 1a,b). Next, we assessed changes in mitochondrial content
in response to FCCP treatment in WT and Atg5 /
MEFs overexpressing YFP-Parkin. FCCP is a potent inducer of
Parkin-mediated mitochondrial autophagy13. In both WT and
Atg5 / MEFs, FCCP treatment led to Parkin translocation
and subsequent clearance of mitochondria (Fig. 1a). Intriguingly,
the rate of mitochondrial clearance, as assessed by immun-
ﬂuorescence staining and western blotting (WB) for the
mitochondrial protein Tom20, were similar in WT and
autophagy-deﬁcient cells (Fig. 1a–c). We conﬁrmed that FCCP-
mediated mitochondrial clearance also occurred in primary MEFs
deﬁcient for the autophagy-related gene Atg7 (Supplementary
Fig. 1c–f). These results indicate that the traditional Atg5/7-
dependent autophagy pathway is not required for mitochondrial
clearance.
The autophagy adaptor p62/Sqstm1 binds to ubiquitinated
mitochondria and is degraded by autophagy along with the
mitochondria14. Although the Atg5 / MEFs are defective
in autophagy, both p62/Sqstm1 and Tom20 were still degraded
after FCCP exposure (Fig. 1d–f). MEFs, which lack detectable
Parkin under normal conditions15, overexpressing control vector
or non-functional Parkinson’s disease-associated mutants
ParkinR42P or ParkinG430D were unable to efﬁciently clear
their mitochondria in response to FCCP (Fig. 1g,h). These
mutants are defective in the ubiquitin-like and RING2 domains,
respectively16. Thus, these ﬁndings indicate that Parkin-mediated
ubiquitination is a prerequisite for degradation of depolarized
mitochondria in autophagy-deﬁcient cells.
Endosomes sequester mitochondria via ESCRT complexes.
To examine whether Atg5/7-independent alternative autophagy
contributed to mitochondrial clearance, we examined Atg5 /
MEFs for the presence of Rab9-positive vesicles4. Although the
number of Rab9-positive vesicles signiﬁcantly increased after
FCCP treatment, there was little co-localization between Rab9
and mitochondria in these cells (Supplementary Fig. 2a–c).
Furthermore, overexpression of Rab9S21N, a dominant-negative
mutant of Rab9 (ref. 17), failed to reduce Parkin-mediated
mitochondrial clearance in Atg5 / MEFs (Supplementary
Fig. 2d,e). Both alternative autophagy and traditional mitophagy
pathways require Ulk1 (refs 4,18). We conﬁrmed that neither
Ulk1 nor its homologue Ulk2 are required for Parkin-mediated
clearance in response to FCCP treatment. In fact, we observed
similar levels of mitochondrial clearance in WT, Ulk1 / ,
Ulk2 / and Ulk1/2 / MEFs overexpressing Parkin
(Supplementary Fig. 3a–d). Thus, these results conﬁrm that
traditional and alternative autophagy are not required for Parkin-
mediated mitochondrial clearance in Atg5 / MEFs.
Next, we sought to ascertain the mechanism of the autophagy-
independent mitochondria clearance. The endosomal–lysosomal
degradation pathway plays a role in cellular quality control by
degrading damaged or excess plasma membrane proteins19.
However, it is currently unknown whether this pathway
also participates in the degradation of entire organelles such
as mitochondria. The small GTPase Rab5 is present on the
early endosomes and is a critical regulator of their biogenesis
and function20. We discovered that mitochondrial depolarization
with FCCP led to a rapid increase in the number of Rab5-positive
early endosomes in WT and Atg5 / MEFs, and that a
signiﬁcant number of these endosomes co-localized with
mitochondria after treatment (Fig. 2a–f). Another deﬁning
characteristic of early endosomes is the generation of the lipid
phosphatidylinositol 3-phosphate (PI(3)P) at the membrane
by the Vps34 PI3K complex21. Several critical Rab5-interacting
proteins bind to PI(3)P at the endsosome22. To monitor activity
of the Vps34 PI3K complex on Rab5-positive endosomes,
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we overexpressed a green ﬂuorescent protein (GFP)-conjugated
PX domain, which speciﬁcally binds PI(3)P at the early
endosomes23. We observed an increase in the co-localization
between p40PX-EGFP and Rab5 in both WT and Atg5 / MEFs
(Fig. 2g–i) after FCCP treatment. These ﬁndings suggest that
endosomal activity and sequestration of dysfunctional
mitochondria into endosomes occur even in cells with intact
autophagy.
There is cross-talk between the various degradation pathways
and it is possible that some of the autophagy molecules might also
function to regulate the endosome–lysosomal degradation
pathway. Beclin1 is a known component of the Vps34 PI3K
complex and there is increased interaction between p40PX-EGFP
and Beclin1 in both WT and Atg5 / MEFs after FCCP
treatment (Supplementary Fig. 4a–c). We also observed















































































































































































Figure 1 | Parkin promotes clearance of mitochondria in autophagy-deﬁcient cells. (a) Representative images of WTand Atg5 / MEFs overexpressing
YFP-Parkin. Cells were ﬁxed at the indicated time points (in hours) after treatment with FCCP (25 mM) and stained with anti-Tom20 to label mitochondria.
Scale bars, 20mm. (b) Quantiﬁcation of WT and Atg5 / MEFs with cleared mitochondria by Tom20 staining after FCCP treatment (n¼ 100 cells
screened for mitochondria in 3 independent experiments). (c) WB time course of Tom20 protein levels in WTand Atg5 / MEFs overexpressing Parkin
after FCCP treatment (25mM). (d) WB for p62 and Tom20 in Atg5 / MEFs overexpressing Ad-bgal or Ad-Parkin after treatment with DMSO or FCCP
(25mM) for 24 h. Band densitometry of p62 (e) and Tom20 (f) protein levels from d (n¼ 3, **Po0.01). (g) Representative images of Atg5 / MEFs
infected with mCherry, mCherry-Parkin, mCherry-ParkinR42P or mCherry-ParkinG430D and treated with DMSO or 25mM FCCP for 24 h. Cells were ﬁxed
and stained with anti-Tom20 to label mitochondria. Arrowheads show co-localizing puncta. Scale bars, 20mm. (h) Quantiﬁcation of Tom20-positive cells
after FCCP treatment (n¼ 300 cells screened for mitochondria in 3 independent experiments, ***Po0.001). Nuclei were counterstained with Hoechst
33342 (blue). All values are means±s.e.m. from independent experiments. Statistical signiﬁcance was calculated using analysis of variance followed by
Dunnett’s test for multiple comparison. Unprocessed original scans of blots are shown in Supplementary Fig. 11.
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Figure 2 | Mitochondrial dysfunction leads to increased number of Rab5-positive endosomes. Representative images of WT (a) and Atg5 /
(b) MEFs overexpressing GFP-Rab5, myc-Parkin and stained with anti-COX IV to label mitochondria. Arrowheads show co-localizing puncta. Scale bars,
20mm. Quantiﬁcation of GFP-Rab5-positive puncta (c) and their co-localization (d) with COX IV-labelled mitochondria in WT cells in response to 25 mM
FCCP (n¼45 cells scored for number of puncta in 3 independent experiments, *Po0.05 and **Po0.01 versus 0 h). Quantiﬁcation of GFP-Rab5-positive
puncta (e) and their co-localization (f) with COX IV-labelled mitochondria in Atg5 / cells in response to 25 mM FCCP (n¼45 cells scored for number of
puncta in 3 independent experiments, *Po0.05, **Po0.01 and ***Po0.001 versus 0 h). (g) Representative images of WT and Atg5 / MEFs
overexpressing p40PX-EGFP after DMSO or FCCP treatment (25mM). Cells were stained with anti-Rab5 to label early endosomes. Scale bars, 20mm.
(h,i) Quantiﬁcation of puncta positive for p40PX-EGFP and Rab5 in WT (h, n¼40 cells scored for number of puncta in 4 independent experiments,
*Po0.05, **Po0.01, ***Po0.001 and ****Po0.0001 versus DMSO) and Atg5 / (i, n¼40 cells scored for number of puncta in 3 independent
experiments, *Po0.05 versus DMSO) cells. (j) WB for Beclin1 and Actin in Atg5 / MEFs transfected with 20 or 40nM Beclin1 siRNA for 96 h.
Quantiﬁcation of Rab5-positive puncta (k) and their co-localization (l) with COX IV-labelled mitochondria in untransfected (un), control (con) or 20 nM
Beclin1 siRNA-transfected Atg5 / cells expressing Parkin in response to DMSO or 25mM FCCP (n¼ 30 cells scored for number of puncta in 4
independent experiments, ***Po0.001). Nuclei were counterstained with Hoechst 33342 (blue). All values are means±s.e.m. from independent
experiments. Statistical signiﬁcance was calculated using analysis of variance followed by Dunnett’s test for multiple comparison. Unprocessed original
scans of blots are shown in Supplementary Fig. 11.
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Atg5 / MEFs in response to FCCP treatment (Supplementary
Fig. 4d–f), suggesting that active Beclin1 is found on the early
endosomes. Moreover, silencing of Beclin1 suppressed the
increase in Rab5-positive endosomes and the co-localization
between Rab5 and mitochondria in Atg5 / MEFs (Fig. 2j–l
and Supplementary Fig. 4g). We conﬁrmed that Ulk1/2 deﬁciency
had no effect on early endosomal activity in response to FCCP
treatment (Supplementary Fig. 3e,f). Thus, our data indicate
that Rab5-mediated mitochondrial clearance requires Beclin1, but
not Ulk1/2 or Rab9.
To further conﬁrm that mitochondria were internalized
into Rab5-positive endosomes, we performed correlated light
and three-dimensional (3D) electron tomography. We observed
labelled mitochondria (mPlum-mito3) co-localizing with
GFP-Rab5 positive early endosomes after FCCP treatment
by confocal microscopy. These co-localization events were
conﬁrmed at high resolution by correlated electron microscopy
(EM) using a nanobody against GFP fused to APEX2 (ref. 24)
(Fig. 3a,b and Supplementary Fig. 5) and subsequent tomographic
analysis (Supplementary Movies 1 and 2). We found several
instances within each cell type of the entire mitochondria
contained in intraluminal vesicles inside single-membrane
endosomes. The electron tomographic volumes conﬁrmed the
presence of mitochondria fully encased within single-membrane
Rab5-positive endosomes. We conﬁrmed that FCCP treatment
resulted in engulfment of depolarized mitochondria into Rab5-
positive vesicles (Supplementary Fig. 6a). Moreover, at these early
time points, within 8 h, there is negligible cell death in response to
the FCCP exposure (Supplementary Fig. 6b). Therefore, it is
unlikely that these mitochondria within early endosomes are a
result of endocytosis from neighbouring dead cells.
Finally, we investigated the mechanism by which mitochondria
are sequestered by early endosomes. The ESCRT complexes bind
to ubiquitinated cargo and pull them into the endosome through
a process of invagination and scission25. We found
co-localization between mitochondria and proteins in the
various ESCRT complexes, Hgs (ESCRT-0), Tsg101 (ESCRT-I),
Snf8 (ESCRT-II) and Chmp3 (ESCRT-III) after treatment with
FCCP in Atg5 / MEFs (Fig. 4a). Furthermore, analysis of the
heavy membrane fraction, which is enriched in mitochondria,
conﬁrmed a signiﬁcant increase in several of these ESCRT
proteins and Rab5 after FCCP treatment (Fig. 4b,c). As the
centrifugation force used to pellet the heavy membrane fraction is
too low to spin down isolated early endosomes26, this suggests the
ESCRT proteins and Rab5 are associated with mitochondria.
In addition, knockdown of Hgs, Tsg101 and Snf8 proteins led
to decreased mitochondrial clearance and increased cell death
in response to FCCP (Supplementary Fig. 7 and Fig. 4d).
Damaged mitochondria, if not cleared, can cause cell death
through release of pro-death factors and reactive oxygen
species3,27. Thus, reduced removal of mitochondria in cells with
ESCRT protein knockdown might be contributing to the
enhanced FCCP-mediated cell death. Interestingly, knockdown
of Chmp3 (ESCRT-III) did not lead to reduced mitochondrial
clearance or signiﬁcantly enhance FCCP-mediated cell death.
This may be due to incomplete knockdown of Chmp3 or
compensation by other subunits in the ESCRT-III complex.
Finally, we identiﬁed a mitochondrion in the process of being
engulfed by an early endosome in an electron tomographic
volume (Fig. 4e and Supplementary Movie 2), which
morphologically supports the ESCRT model of membrane
invagination and subsequent scission.
Mitochondria-containing endosomes mature and are degraded.
Early endosomes mature into late endosomes before fusing
with lysosomes and this maturation involves a switch from Rab5
to Rab7 (ref. 28). We found that there was a signiﬁcant increase
in the number of Rab7-positive endosomes, and that a signiﬁcant
number of mitochondria co-localized with Rab7 in Atg5 /


















Figure 3 | Mitochondria are sequestered inside Rab5-positive endosomes. (a) Confocal microscopy of WT (a) and Atg5 / (b) MEFs transfected with
GFP-Rab5, VHH-APEX2, mPlum-mito3 and HA-Parkin, and treated with DMSO or FCCP (25 mM) for 4 h. Scale bars, 20mm. Overlay of confocal inset
with electron microscopy of the same cell. Confocal images and electron micrographs of co-localizing puncta (boxes) are shown enlarged and indicated
with arrowheads. Note: ﬁrst inset in a is found adjacent to the nuclear envelope, but within the cytosol. Scale bars, 200nm.
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with lysosomes where the cargo is degraded. In agreement with
this, we observed increased lysosomal activity and a signiﬁcant
number of mitochondria inside LAMP2-positive lysosomes in
Atg5 / MEFs after FCCP treatment (Fig. 5d–f). Overall,
these ﬁndings suggest that dysfunctional mitochondria are
sequestered inside early endosomes, which mature into late
endosomes, and are subsequently delivered to lysosomes for
degradation.
Mitochondria can modulate their shape by undergoing



























































































































































































































Figure 4 | ESCRT complexes participate in sequestration of mitochondria. (a) Confocal maximal image projections of Atg5 / MEFs infected with
mCherry-Parkin and treated with DMSO or 25 mM FCCP for the indicated time. Cells were stained with anti-Tim23 or anti-Tom20 (white) to label
mitochondria, and for the indicated ESCRT protein (green). Enlarged boxes are single optical slices with arrowheads showing co-localization. Scale bars,
20mm. (b) Representative WB of isolation of the mitochondrial enriched heavy membrane fraction after 0, 1 or 4 h of 25mM FCCP treatment in Atg5 /
MEFs overexpressing Parkin. Tim23 is shown as a mitochondrial loading control. (c) Band densitometry of protein levels from b (n¼ 3, *Po0.05 and
**Po0.01; ns¼ not signiﬁcant versus 0 h FCCP). (d) Quantiﬁcation of cell death. Atg5 / MEFs were exposed to DMSO or FCCP (25mM) for 24 h after
siRNA knockdown and then stained with Po-Pro-3. (n¼ 200 screened for cell death in 3 independent experiments, *Po0.05, **Po0.01, ***Po0.001;
ns¼ not signiﬁcant). (e) Single slice of an electron tomogram showing mitochondria (red) partially sequestered by an early endosome (green) in Atg5 /
MEFs (left). Scale bar, 200nm. The 3D reconstructed model of mitochondria (red) and endosome (green, right). Movie of the full tomogram of this puncta
can be found in Supplementary Movie 2. All values are means±s.e.m. from independent experiments. Statistical signiﬁcance was calculated using analysis
of variance followed by Dunnett’s test for multiple comparison. Unprocessed original scans of blots are shown in Supplementary Fig. 11.
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segregation and selective removal of depolarized mitochondrial
fragments by autophagy29. However, inhibiting Drp1-mediated
mitochondrial ﬁssion by overexpressing the dominant-negative
Drp1K38E did not affect Parkin-mediated mitochondrial
clearance in Atg5 / MEFs (Supplementary Fig. 8a,b).
Similarly, promoting mitochondrial fusion by overexpression
of Mfn2 or Mfn2(T111E/S442E), which lacks mitochondrial
fusion activity but is a constitutive Parkin receptor10,13, did
not affect Parkin-mediated mitochondrial clearance in response
to FCCP treatment in Atg5 / MEFs (Supplementary Fig. 8c–f).
Thus, our data suggest that Drp1-mediated mitochondrial
ﬁssion is not required for clearance of mitochondria by Parkin
in Atg5 / MEFs. In fact, Drp1-deﬁcient cells have
been previously reported to undergo mitochondrial loss30,
suggesting that there is an alternative mechanism by which
mitochondria can fragment to release them from the network
and facilitate their clearance. Whether this mechanism is speciﬁc
for mitochondrial clearance or is involved in the general
homeostasis of mitochondria remains to be seen.
Early endosomal pathway is activated before autophagy. Next,
we examined whether the activation of the autophagy
and endosomal pathways was simultaneous or sequential in
WT cells. Interestingly, we observed a rapid, but transient,
increase in the number of Rab5-positive endosomes in response
to FCCP treatment, whereas the number of autophagosomes
increased progressively but more slowly over time (Fig. 6a,b).
Thus, the endosomal pathway might be activated as a ﬁrst
response to clear damaged mitochondria.
We also conﬁrmed that degradation of mitochondria
by the endosomal pathway was not limited to FCCP treatment.
FCCP depolarizes mitochondria by increasing membrane
permeability to Hþ , whereas valinomycin depolarizes mitochon-
dria by permeabilizing the membrane to Kþ . We found that
valinomycin treatment led to a signiﬁcant increase in Rab5-
positive puncta, in both WT and Atg5 / MEFs (Fig. 6c–e).
Valinomycin treatment also resulted in clearance of mitochondria
in both WT and Atg5 / MEFs in the presence of
Parkin (Fig. 6f,g). Mitochondrial clearance can also be
directly mediated by mitophagy receptors such as Nix and Bnip3
(ref. 31). These proteins localize to the outer mitochondrial
membrane where they induce mitochondrial dysfunction
and clearance. We found that overexpression of Bnip3 alone
led to efﬁcient clearance of mitochondria in both WT and
Atg5 / MEFs (Fig. 6h,i). We also conﬁrmed that over-
expression of Bnip3 and Bnip3W18A, a mutant unable to dock
mitochondria to autophagosomes32, led to increased
co-localization between p40PX-EGFP and Rab5 in Atg5 /
MEFs (Fig. 6j,k). Bnip3 is regulated by hypoxia and we conﬁ-
rmed that exposure to hypoxia resulted in signiﬁcant
mitochondrial clearance in Atg5 / MEFs by 24 h (Supple-
mentary Fig. 9a). Also, overexpression of the Rab5 dominant
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Figure 5 | Mitochondria in late endosomes are delivered to lysosomes. (a) Representative images of Atg5 / MEFs overexpressing GFP-Rab7,
HA-Parkin and stained with anti-COX IV to label mitochondria. Arrowheads show co-localizing puncta. Scale bars, 20mm. (b,c) Quantiﬁcation of
GFP-Rab7-positive puncta (b) and their co-localization (c) with COX IV-labelled mitochondria in Atg5 / MEFs in response to 25mM FCCP (n¼45 cells
scored for number of puncta in 3 independent experiments, *Po0.05, **Po0.01 and ***Po0.001 versus 0 h). (d) Representative images of cells
overexpressing mitoDsRed, HA-Parkin and stained with anti-Lamp2 to label lysosomes. Arrowheads show co-localizing puncta. Scale bars, 20 mm.
(e,f) Quantiﬁcation of Lamp2-positive puncta (e) and their co-localization (f) with mitoDsRed in Atg5 / MEFs in response to 25 mM FCCP (n¼40 cells
scored for number of puncta in 3 independent experiments, *Po0.05 and **Po0.01 versus 0 h). Nuclei were counterstained with Hoechst 33342 (blue).
All values are means±s.e.m. from independent experiments. Statistical signiﬁcance was calculated using analysis of variance followed by Dunnett’s test for
multiple comparison.
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mediated cell death in Atg5 / MEFs (Supplementary Fig. 9b).
In contrast, DNA damage by Actinomycin D, an inhibitor
for RNA synthesis that induces apoptosis33, did not lead to an
increase in Rab5-positive early endosomes (Supplementary
Fig. 9c,d) and did not promote mitochondrial clearance in





























































































































































































































Figure 6 | Mitochondrial stress leads to rapid increase in Rab5-positive endosomes. (a) Representative images of WT MEFs overexpressing GFP-LC3,
treated with 25 mM FCCP for the indicated time and stained with anti-Rab5. Scale bars, 20mm. (b) Quantiﬁcation of Rab5 and GFP-LC3-positive vesicles in
WT cells (n¼40 cells scored for number of puncta in 3 independent experiments, *Po0.05 and **Po0.01 versus 0 h for Rab5, #Po0.05 versus 0 h for
GFP-LC3). (c) Representative images of WTand Atg5 / MEFs infected with mCherry-Parkin and treated with DMSO or 10 mM valinomycin for 4 h. After
treatment, cells were ﬁxed and stained with anti-Rab5. Scale bars, 20mm. (d,e) Quantiﬁcation of Rab5-positive vesicles in WT (d) and Atg5 /
(e) cells (n¼ 30 cells scored for number of puncta in 3 independent experiments, **Po0.01 and ***Po0.001). (f) Representative images of WT and
Atg5 / MEFs infected with mCherry-Parkin and treated with DMSO or 10mM valinomycin for 24 h. After treatment, cells were ﬁxed and stained with
anti-Tom20. Scale bars, 20mm. (g) Quantiﬁcation of mitochondrial clearance in response to valinomycin (n¼ 200 cells screened for mitochondria in
3 independent experiments, ***Po0.001 versus DMSO). (h) Representative images of mitochondrial clearance in WT or Atg5 / MEFs infected with
mito-GFP plus b-gal or Bnip3 for 24 h. Scale bars, 20mm. (i) Quantiﬁcation of mitochondrial clearance in response to Bnip3 (n¼ 100 cells screened for
mitochondria in 3 independent experiments, ***Po0.001 versus b-gal). (j) Representative images of Atg5 / MEFs transfected with myc, Bnip3 or
Bnip3W18A plus p40PX-EGFP for 24 h and stained with anti-Rab5. Scale bars, 10mm. (k) Quantiﬁcation of puncta positive for p40PX-EGFP and Rab5 in
Atg5 / cells (n¼ 35 cells scored for number of puncta in 4 independent experiments, *Po0.05 versus myc). Nuclei were counterstained with Hoechst
33342 (blue). All values are means±s.e.m. from independent experiments. Statistical signiﬁcance was calculated using analysis of variance followed by
Dunnett’s test for multiple comparison.
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indicate that mitochondrial stress, but not DNA damage,
leads to activation of the endosomal pathway, which correlates
with increased mitochondrial clearance.
Endosomal removal of mitochondria diminishes cell death.
To explore the functional importance of the endosomal degra-
dation pathway, we used 3-methyladenine (3-MA) to pharma-
cologically inhibit the endosomal–lysosomal pathway. 3-MA is a
PI3K inhibitor that inhibits Vps34 and disrupts formation of both
endosomes and autophagosomes34. We found that inhibition of
Vps34 by 3-MA led to increased susceptibility to FCCP-mediated
cell death in WT and Atg5 / MEFs (Fig. 7a,b). In addition,
knockdown of the late endosome protein Rab7 led to increased
FCCP-mediated cell death in WT and Atg5 / MEFs (Fig. 7c–e).
Rab5 exists as three isoforms with overlapping functions and all
three isoforms are expressed in MEFs (Supplementary Fig. 10a,b).
The dominant-negative Rab5S34N targets all three isoforms of
Rab5 and effectively reduced FCCP-mediated mitochondrial
clearance in cells (Supplementary Fig. 10d,e). Overexpression
of Rab5S34N also caused increased FCCP-mediated cell death
in both WT and Atg5 / MEFs. Consistent with the previous
experiment, the Atg5 / MEFs were signiﬁcantly more
susceptible to Rab5 inhibition than WT cells (Fig. 7f).
Interestingly, we observed that inhibition of the endosomal
pathway alone led to an increase in cell death in both WT and
Atg5 / MEFs, conﬁrming the importance of the endosomal
pathway in cellular homeostasis and in clearing damaged
mitochondria. However, because the endosomal pathway





















































































































































































































































Figure 7 | Abrogation of the endosomal–lysosomal degradation pathway increases susceptibility to cell death. (a,b) Quantiﬁcation of cell death in
response to FCCP þ/ 3-MA treatment. WT (a) or Atg5 / (b) MEFs expressing Parkin were incubated with 5mM 3-MA and DMSO or FCCP (25 mM)
for 24 h. Cell death was assessed by Yo-Pro-1 uptake (n¼ 350 cells screened for cell death in 3 independent experiments, *Po0.05, **Po0.01 and
***Po0.001). (c) WB of Rab7 in Atg5 / MEFs after siRNA transfection. (d,e) Quantiﬁcation of cell death in WT (d) or Atg5 / (e) cells exposed to
DMSO or FCCP (25mM) for 24 h after siRNA knockdown and then stained with Yo-Pro-1 (d: n¼470, e: n¼ 175 cells, screened for cell death in
3 independent experiments, *Po0.05, **Po0.01 and ***Po0.001). (f) Quantiﬁcation of cell death in WT and Atg5 / MEFs infected with myc-Parkin
and bgal (con) or Rab5S34N. Cells were exposed to DMSO or FCCP (25 mM) for 24 h. Cell death was assessed by Po-Pro-3 uptake (n¼ 160 cells screened
for cell death in 4 independent experiments, **Po0.01 and ****Po0.0001). (g) WB for LC3 and p62 levels in WT MEFs expressing Parkin infected with
b-gal (control) or Rab5S34N and treated with DMSO or FCCP (25 mM) for 4 h. (h,i) Band densitometry of LC3II (h) and p62 (i) protein levels
(n¼ 3, *Po0.05 and **Po0.01, ns¼ not signiﬁcant). All values are means±s.e.m. from independent experiments. Statistical signiﬁcance was calculated
using analysis of variance followed by Dunnett’s test for multiple comparison. Unprocessed original scans of blots are shown in Supplementary Fig. 11.
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possibility that these results are inﬂuenced by other stresses
induced by inhibition of the endosomal pathway.
To determine why WT cells were less susceptible to abrogation
of the endosomal pathway, we examined the relationship between
the autophagy and endosomal pathways in WT cells. Interest-
ingly, inhibition of the endosomal pathway led to increased
autophagic activity under both baseline conditions and after
stress (Fig. 7g–i). Although abrogating Rab5 alone
led to increased autophagic activity, we did not observe an
increase in mitophagic activity under baseline conditions
(Supplementary Fig. 10f,g). Assessing mitophagy at later time
points is challenging due to the amount of cell death induced by
FCCP in cells overexpressing Rab5S34N. Thus, this suggests that
there is cross-talk between the two pathways, and that the
autophagy pathway can potentially compensate when the
endosomal pathway is impaired. However, further studies are
needed to examine the relationship between these pathways.
Maintaining a functional population of mitochondria is critical
for cardiac myocyte function. They are highly active cells
that require large amounts of energy supplied by mitochondrial
oxidative phosphorylation. As myocytes are postmitotic, it is
critical for these cells to efﬁciently remove dysfunctional
mitochondria before they can cause harm. Therefore, we
investigated whether the endosomal pathway contributes to
clearing damaged mitochondria in myocytes. Myocardial ischae-
mia/reperfusion is associated with mitochondrial damage
and activation of mitophagy35. Interestingly, we found that
simulated ischaemia/reperfusion (sI/R) led to a rapid transient
increase in the number of Rab5-positive endosomes on
reperfusion (Fig. 8a,b). sI/R has many effects on the cell, so it is
currently unclear whether mitochondrial dysfunction is the only
trigger for increased endosome formation. However, we observed
that many of the endosomes co-localized with mitochondria
in the myocytes (Fig. 8c). In addition, all three isoforms of Rab5
are expressed in the heart (Supplementary Fig. 10c) and
overexpression of Rab5S34N to inhibit Rab5 activity led to
increased sI/R-mediated cell death (Fig. 8d). Finally, we
conﬁrmed that Beclin1 regulates endosomal activity in
myocytes in response to stress. Knockdown of Beclin1 using
Ad-shRNA completely abrogated the increase in Rab5-positive
endosomes and their co-localization with mitochondria in
myocytes in response to sI/R or FCCP treatment (Fig. 8e–j).
These data conﬁrm that Rab5 and the endosomal pathway
also contribute to clearing impaired mitochondria in cardiac
myocytes.
Discussion
For a long time, it was believed that autophagy was the
only pathway involved in degrading organelles such as mitochon-
dria. In this study, we have uncovered a previously unidentiﬁed
mechanism of mitochondrial clearance that exists in cells.
Our data suggest that depolarized mitochondria can be
sequestered in single-membrane Rab5-positive endosomes
via the ESCRT machinery, and that these vesicles mature into
Rab7-positive late endosomes before being delivered to lysosomes
for degradation (Fig. 9). This pathway is also activated in
cells with functional autophagy and disrupting the endosomal
pathway impaired mitochondrial clearance and increased the
cells’ susceptibility to death, conﬁrming the physiological
importance of this pathway in cells.
Our data suggest that the delivery of mitochondria into
endosomes is distinct from autophagic engulfment. The
3D reconstruction of electron tomographic volumes clearly shows
that mitochondria are engulfed via a process involving invagina-
tion of the vesicle membrane. Our data also show that
mitochondria inside the vesicles are surrounded by intraluminal
membranes. These are produced by the invagination and scission
of the limiting membrane and is reminiscent of ESCRT-
dependent processes. The ESCRT complexes are responsible for
cargo capturing and sorting, as well as membrane invagination
and scission36. This is in contrast to autophagy, where a cup-
shaped phagophore membrane binds to ubiquitinated cargo via
autophagy receptors such as p62 and Nbr1, and then encloses
around the cargo to form a double membraned autophagosome3.
Our data further suggest that degradation of mitochondria
in response to FCCP-mediated depolarization in both WT and
Atg5 / is dependent on the presence of Parkin. Parkin is an
E3 ubiquitin ligase that ubiquitinates proteins in the outer
mitochondrial membrane3. Both autophagy receptors, such as
p62 and Nbr1, and ESCRT-0 bind ubiquitinated cargo
to be degraded3,36. This suggests that the primary function of
Parkin is to label mitochondria for degradation. In contrast
to our study, Narendra et al.11 reported that Parkin did not
promote clearance in Atg5 / MEFs in response to the
mitochondrial uncoupler CCCP. We believe this discrepancy
is due to differences in the dose. This study used a lower dose
than us and they also reported much lower levels of Parkin-
mediated mitochondrial clearance in WT MEFs than our
study. Clearly, a lower dose will lead to reduced and/or a
slower rate of clearance.
A recent study reported that mitochondria can also be directly
delivered to lysosomes via catalytically inactivated glyceraldehyde
3-phosphate dehydrogenase5. An impairment in this process,
which is also known as microautophagy37, plays a role in
Huntington’s disease5. When there is limited damage,
the mitochondrion can repair itself by eliminating damaged
lipids and proteins via mitochondrial-derived vesicles (MDVs)
that bud off and then fuse with lysosomes38. Interestingly, it has
been shown that transcellular degradation of mitochondria exists
in certain areas in the central nervous sytem where mitochondria
are internalized and degraded by adjacent cells, more speciﬁcally
astrocytes39. Thus, it is clear that multiple quality control
mechanisms exist to ensure rapid clearance of dysfunctional
mitochondria. The redundancy ensures that mitochondria can be
removed before they cause unnecessary cell death even if one of
the pathways is impaired or not functioning properly. Our data
suggest that the endosomal–lysosomal system is but one pathway
through which mitochondria can clear. Clearly, multiple levels
of mitochondrial quality control exist to ensure mitochondrial
health, and it is very possible that additional, currently
unidentiﬁed, pathways of mitochondrial quality control exist
in cells.
In addition, our data show that activation of endosomal-
mediated mitochondrial clearance precedes activation of
the autophagy pathway. We propose that uptake of mitochondria
into endosomes acts as a ﬁrst line of defense to rapidly eliminate
dysfunctional mitochondria. Early endosomes are contin-
uously synthesized and exist in a network in cells20, whereas
autophagosomes are synthesized de novo on demand40.
Therefore, dysfunctional mitochondria can be more rapidly
sequestered by the early endosomes. However, it is likely to be
that if the number of damaged mitochondria exceeds the capacity
of endosomal-mediated degradation, then the autophagy pathway
is also activated. A similar coordination and sequential activation
has been observed for the traditional autophagy and chaperon-
mediated autophagy pathways in response to stress such
as starvation and oxidative stress41. Traditional autophagy is
rapidly activated in response to stress but then there is a switch
to chaperon-mediated autophagy if the stress is prolonged. Future
studies need to determine the context and timing of activation
of these various pathways in cells. Our data also show that
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autophagic activity is increased when Rab5 activity is abrogated,
suggesting that autophagic degradation is compensating
when endosomal activity is impaired.
It is clear that many of the proteins involved in cellular quality
control regulate multiple quality control pathways. For instance,










































































































































































































































































































Figure 8 | Activation of endosomal-mediated mitochondrial degradation in cardiac myocytes. (a) Representative images of neonatal myocytes
subjected to normoxia or sI/R. After treatment, cells were ﬁxed and stained with anti-Rab5 and anti-COX IV. Arrowheads show co-localizing puncta. Scale
bars, 10mm. (b,c) Quantiﬁcation of Rab5-positive puncta (b) and their co-localization (c) with COX IV-labelled mitochondria in neonatal cardiac myocytes
(n¼ 36 cells scored for number of puncta in 3 independent experiments, *Po0.05 versus normoxia). (d) Quantiﬁcation of cell death. Cells were exposed to
normoxia or 2 h of simulated ischaemia plus 8 h of reperfusion. Cell death was assessed by propidium iodide staining (n¼ 170 cells screened for cell death
in 3 independent experiments, **Po0.01). (e) WB of Beclin1 knockdown in myocytes. (un¼ uninfected, scr¼ scramble shRNA, parentheses indicate MOI)
(f) Representative images of neonatal myocytes after Beclin1 knockdown. After treatment, cells were stained with anti-Rab5 and anti-COX IV. Scale bars,
10mm. Arrowheads show colocalization. Enlarged boxes without arrowheads show non-co-localizing puncta. (g,h) Quantiﬁcation of Rab5-positive puncta
(g) and their co-localization (h) with COX IV-labelled mitochondria in neonatal cardiac myocytes. Cells were treated with scramble (scr) or Beclin1 shRNA
(MOI¼ 50) and subjected to normoxia or 2 h of simulated ischaemia plus 60min of reperfusion before ﬁxation and staining with anti-Rab5 and anti-COX
IV (n¼ 30 cells scored for number of puncta in 3 independent experiments, ***Po0.001). (i,j) Quantiﬁcation of Rab5-positive puncta (i) and their
co-localization with COX IV-labelled mitochondria (j) in neonatal cardiac myocytes. Cells were subjected to FCCP (10mM) for 6 h before ﬁxation and
staining with anti-Rab5 and anti-COX IV (n¼ 30 cells scored for number of puncta in 3 independent experiments, *Po0.05, **Po0.01 and ****Po0.0001).
Nuclei were counterstained with Hoechst 33342 (blue). All values are means±s.e.m. from independent experiments. Statistical signiﬁcance was calculated
using analysis of variance followed by Dunnett’s test for multiple comparison. Unprocessed original scans of blots are shown in Supplementary Fig. 11.
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traditional and alternative autophagy pathways4,42. Similarly,
the Rab proteins are well-known for their roles in regulating
endosomal trafﬁcking, but recent studies have found that some
of the Rab proteins can also regulate autophagy43,44. Parkin
is known to mark mitochondria for autophagic degradation
and here we demonstrate that Parkin also labels mitochondria
for endosomes. Both endosomes and autophagosomes recognize
ubiquitinated targets45. Parkin is also involved in the formation of
a subset of MDVs that are destined for delivery to late
endosomes/lysosomes46. Although the Rab5 pathway described
in our study and formation of MDVs both use the endosomal–
lysosomal degradation pathway and are independent of Atg5,
these are clearly two distinct mechanisms of mitochondrial
quality control. First, we observe that entire mitochondria are
sequestered inside large (B500 nm) single-membrane Rab5-
positive early endosomes. In contrast, MDVs are small vesicles
(70–150 nm) containing select mitochondrial proteins and lipids
that bud off the outer mitochondrial membrane mitochondria,
which are then delivered directly to LAMP1-positive late
endosomes/lysosomes. Finally, our data show that the
mitochondria are captured by the early endosomes through
ESCRT-mediated membrane invagination and subsequent
scission, whereas MDVs directly fuse with late endosomes/
lysosomes via Stx17 and SNARE complexes to deliver their
content47. Thus, it is likely to be that formation of MDVs occurs
when there is limited damage in an attempt to avoid degradation
of the entire mitochondrion. However, when the damage is too
extensive, then the entire mitochondrion is sequestered inside a
Rab5-positive early endosome.
In addition, there are receptors on mitochondria that directly
target them to autophagosomes bypassing the need for
Parkin. Interestingly, we found that one of these receptors,
Bnip3, induced increased endosomal activity in autophagy-
deﬁcient MEFs, which correlated with mitochondrial clearance.
However, whether Bnip3 and other known mitophagy receptors
use endosomal-mediated degradation of mitochondria and
the ESCRT machinery needs to be further investigated. There is
some evidence in the literature that the ESCRT machinery
can participate in autophagic degradation of cargo. It was recently
reported that the ﬁssion yeast Nbr1, a homologue of the
mammalian autophagy receptor NBR1, facilitated the transport
of two cytosolic hydrolases into vacuoles via the ESCRT
proteins48. In addition, the ESCRT machinery has been
reported to participate in delivering autophagic cargo into
multivesicular bodies in a process known as microautophagy49.
In this process, soluble proteins containing the KFERQ-like
targeting motif are delivered into late endosomes/multivesicular
bodies in a manner dependent on ESCRTs and the chaperone
protein Hsc70 (ref. 49). Overall, this suggests that there is a lot of
cross-talk and overlap between the various degradation pathways.
Although overexpression of proteins is very useful tool to
study protein function and signalling pathways, there is always
the concern that the overexpression interferes with normal
cell function. To study Parkin-mediated mitochondrial degrada-
tion, we relied on overexpression of Parkin in cells. One
advantage is that we can study Parkin and mutants in cells such
as MEFs that have no detectable levels of endogenous Parkin.
Second, using ﬂuorescently tagged Parkin has allowed us and
numerous other investigators11,13,50 to monitor translocation of
Parkin to mitochondria in live cells in response to stress. The
disadvantages are that to visualize and study Parkin in cells,
the protein is expressed at levels that are well above the normal
physiological levels in cells and tissues. However, we have
conﬁrmed our key ﬁndings in neonatal myocytes that express
endogenous Parkin. Furthermore, studies have reported that
Parkin is signiﬁcantly upregulated in tissues in response to
various stressors7,8,51–52. Thus, Parkin overexpression studies are
more likely to mimic signalling events in diseases or stressed
tissues rather than under baseline conditions. Another limitation
of our study is that it is still unclear whether the increase in
Rab5þ endosomes observed in response to FCCP treatment is
predominantly due to mitochondrial stress or whether signals
from dysfunctional late endosomes/lysosomes are also
contributing to this increase. Although FCCP is a potent
inducer of Parkin-mediated mitochondrial degradation11, it
can also perturb V-ATPase-mediated acidiﬁcation of
endosomal/lysosomal compartments53. These pH changes in











Figure 9 | Model of endosomal sequestration and degradation of a
damaged mitochondrion. Stress, such as FCCP or sI/R, induces Parkin
recruitment and ubiquitination of proteins in the outer mitochondrial
membrane. The ubiquitinated mitochondrion is captured by the
ESCRT complexes on the early endosome. The ESCRT machinery induces
invagination and subsequent scission of the endosome membrane, leading
to internalization of the mitochondrion in the lumen of the endosome.
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signalling54,55, which can affect biogenesis of endosomes. For
instance, the transcription factor EB (TFEB) regulates expression
of genes involved in endosomal and lysosomal biogenesis and
activity. Inhibition of lysosomal function was reported to reduce
MTORC1-dependent phosphorylation of TFEB, resulting in
its nuclear translocation and subsequent increased expression of
its target genes56. Thus, it is possible that disruption of lysosomal
acidiﬁcation and function by FCCP could contribute to increased
endosomal biogenesis via TFEB activation.
In conclusion, our studies have provided insights into a
new mitochondrial quality control pathway as shown in our
model in Fig. 9. Future studies need to validate this pathway
in vivo and to investigate the functional relevance of this pathway
to human health and in disease. Mitochondrial quality control
involves a very complex network of proteins and pathways, many
of which have probably not been identiﬁed yet. Considering
that mitochondrial dysfunction contributes to neurodegenerative
and cardiovascular diseases, it is critical to gain increased
understanding of the pathways that regulate mitochondrial
health. This will ultimately allow for the identiﬁcation of novel
therapeutic targets in these pathways that could lead to effective
new treatments for diseases.
Methods
Antibodies. The following antibodies were used for immunoﬂuorescence (IF)
and WB experiments: Actin (WB 1:2,000; Sigma; A4700), Beclin1 (WB 1:1,000;
Santa Cruz; sc-11427), Chmp3 (IF 1:100; WB 1:1,000; Santa Cruz; sc-67228),
Gapdh (WB 1:2,000, Genetex; GTX627408), Hgs (IF 1:100; WB 1:1,000; Abcam;
ab155539), Lamp2 (IF 1:100; Abcam; ab13524), Lamp2 (WB 1:1,000; Santa Cruz;
sc-18822), LC3 (WB 1:1,000; Cell Signaling; 4108), OxPhos Complex IV subunit 1
(IF 1:100; Life Technologies; 459600), p62 (WB 1:1,000; ARP; 03-GP62-C), Rab5
(IF 1:100; WB 1:1,000; Cell Signaling; 3547), Rab7 (WB 1:1,000; Cell Signaling;
9367), Snf8 (IF 1:100; WB 1:1,000; Santa Cruz; sc-390747), Tim23 (IF 1:100;
WB 1:1,000; BD Biosciences; 611222), Tom20 (IF 1:200; WB 1:1,000; Santa Cruz;
sc-11415), Tsg101 (IF 1:100; WB 1:1,000; Abcam; ab83) and tubulin (WB 1:2,000;
Sigma; T6074). Secondary antibodies used were goat anti-mouse or goat anti-rabbit
HRP, Alexa Fluor 488 or 594 (Life Technologies).
Cells and culture conditions. MEFs were maintained in MEF culture media
(DMEM (Life Technologies) supplemented with 10% fetal bovine serum
(Life Technologies), 100Uml 1 penicillin (Gemini) and 100 mgml 1 strepto-
mycin (Gemini)), and cultured in a 5% CO2 atmosphere at 37 C. WT and
Atg5 / MEFs were generously provided by Dr Noboru Mizushima
(The University of Tokyo, Japan); primary WT and Atg7 / MEFs were kindly
provided by Dr Toren Finkel (NIH, USA)57; WT and Ulk1 / MEFs were
generously provided by Dr Mondira Kundu (St Jude Children’s Research Hospital,
USA)18; Ulk2 / and Ulk1/2 / MEFs were obtained from Cancer Research
Technology Ltd. None of these cell lines are listed in the database of commonly
misidentiﬁed cell lines maintained by ICLAC. Neonatal cardiac myocytes were
prepared from 1- to 2-day-old Sprague–Dawley rats by enzymatic digestion of the
hearts58 and subsequent plating on gelatin-coated Nunc Lab-Tek Chamber Slides
(Thermo Scientiﬁc) in a 4:1 ratio DMEM (Life Technologies) to M199
(Life Technologies) plus 10% fetal bovine serum (Life Technologies), 100Uml 1
penicillin (Gemini), 100mgml 1 streptomycin (Gemini) and 100mM BrdU
(Sigma). Myocytes were cultured in serum-free media at 37 C with 5% CO2. Cell
lines have not been tested for mycoplasma contamination. sI/R was initiated by
incubating myocytes in ischemic buffer (125mM NaCl, 8mM KCl, 1.2mM
KH2PO4, 1.25mM MgSO4, 1.2mM CaCl2, 6.25mM NaHCO3, 20mM 2-
deoxyglucose, 5mM Na-lactate, 20mM HEPES pH 6.6) and placing the dishes in
hypoxic pouches (GasPak EZ, BD Biosciences), equilibrated to 95% N2, 5% CO2.
Reperfusion was initiated by changing to Krebs–Henseleit buffer (110mM NaCl,
4.7mM KCl, 1.2mM KH2PO4, 1.25mM MgSO4, 1.2mM CaCl2, 25mM NaHCO3,
15mM glucose, 20mM HEPES pH 7.4). Normoxic control cells were maintained in
Krebs–Henseleit buffer throughout the experiment. All animal protocols were in
accordance with institutional guidelines and approved by the Institutional Animal
Care and Use Committee of the University of California, San Diego. Hypoxia
experiments were performed by placing cells in hypoxic buffer (MEF culture media
as described above, plus 20mM HEPES pH 7.4 (Gibco)) and placing the dishes
in a 5% CO2 atmosphere at 37 C for normoxic controls, or in hypoxic pouches
(GasPak EZ, BD Biosciences), equilibrated to 95% N2, 5% CO2 for hypoxic
experimental conditions.
Transient transfections and siRNA knockdown. Cells were transiently
transfected with DNA using Fugene 6 Transfection Reagent (Promega) according
to the manufacturer’s instructions. Generation of Bnip3W18A was prepared
using site directed mutagenesis by PCR with Bnip3 WT as a template32.
YFP-Parkin was a gift from Richard Youle (Addgene plasmid 23955)11;
Myc-Parkin and HA-Parkin were gifts from Ted Dawson (Addgene plasmids
17612 and 17613)59; EGFP-Rab5S34N was a gift from Qing Zhong
(Addgene plasmid 28045)60; p40PX-EGFP was a gift from Michael Yaffe (Addgene
plasmid 19010)23; GFP-Rab9 and GFP-Rab9S21N were gifts from Richard Pagano
(Addgene plasmids 12663 and 12664)17; mPlum-Mito-3 was
a gift from Michael Davidson (Addgene plasmid 55988)61; and GFP-Rab5 and
GFP-Rab7 were gifts from JoAnn Trejo (UCSD, USA). Beclin1 knockdown
experiments were performed by transfecting 20 nM AllStars Negative Control
(Qiagen, number SI03650318; seq: 50-CAGGGTATCGACGATTACAAA-30)
or Beclin 1 small interfering RNA (siRNA) (Sigma, siRNA ID:
SASI_Mm01_00048143; seq: 50-CUGAGAAUGAAUGUCAGAA-30) with
HiPerFect Transfection Reagent (Qiagen) for 96 h, according to the manufacturer’s
instructions. Rab7 knockdown experiments were performed by transfecting
20 nM Rab7 siRNA SMARTpool (Dharmacon, no. L-040859-02-0005; seqs:
50-CAGCUGGAGAGACGAGUUU-30 , 50-CGACAGACUUGUUACCAUG-30,
50-GAGCGGACUUUCUGACCAA-30 and 50-CAGAAGUGGAACUGUACAA-30)
or AllStars Negative Control siRNA with Dharmafect 4 Transfection Reagent
(Dharmacon) for 96 h, according to the manufacturer’s instructions. Knockdown
of ESCRT proteins was performed by transfecting 20 nM AllStars Negative Control,
80 nM Hgs siRNA SMARTpool (Dharmacon, number L-055516-01-0005, seqs:
50-CAAGAUACCUCAACCGGAA-30 , 50-AAGCAUCACUGCCGAGCAU-30 ,
50-CGUACAAUAUGCAGAAUCU-30 and 50-AGACAGACUCUCAGCCCAU-30),
40 nM Tsg101 siRNA (Sigma, siRNA ID: SASI_Mm01_00065312; seq:
50-GGUACAAUCCCAGUGCGUU-30), 80 nM Snf8 siRNA SMARTpool
(Dharmacon, number L-049190-01-0005; seqs: 50-UCGGAAUGGAGGU
CUGAUA-30 , 50-GACUGAGUGUGGAGGGGUA-30 , 50-CAAGAGA
UCCGGAAGAAUC-30, 50-CUACAUCAGCAGGUGUUAA-30), or 100 nM
Chmp3 siRNA SMARTpool (Dharmacon, no. L-062411-01-0005; seqs:
50-GUGAAAUGCAGGACAGUUA-30, 50-GGGUUAACGUGCUGUGUUG-30 ,
50-UGAGAAGAGUAGAUUGAAU-30 and 50-GUACAGAAUGGCU
UUGUUA-30), with HiPerFect Transfection Reagent (Qiagen) for 96 h,
according to the manufacturer’s instructions.
Adenoviral infections and shRNA knockdown. Cells were infected with
adenoviruses in DMEMþ 2% heat-inactivated serum for 3 h and rescued with
growth media. Experiments were performed 20 h later. Generation of adenoviruses
encoding mCherry-Parkin, mCherry-ParkinR42P and mCherry-ParkinG430D
were previously described7. The Bnip3 adenovirus was previously described32.
The myc-Parkin, p40PX-EGFP and Drp1K38E adenoviruses were generated
using the pENTR directional TOPO cloning kit (Invitrogen) followed by
recombination into the pAd/CMV/V5-DEST Gateway vector (Invitrogen).
Ad-GFP-Rab5S34N was a gift from Pyong Woo Park (Boston Children’s Hospital,
USA)62; Mfn2WT and Mfn2EE viruses were provided by Gerald W. Dorn II13.
Ad-Beclin1 short hairpin RNA (shRNA) was provided by Dr Junichi Sadoshima63.
Knockdown experiments were performed by infecting cells with Ad-U6-scramble-
RNAi control (Vector Biolabs, 1122) or Ad-Beclin1 shRNA and experiments were
performed 96 h later.
Cell death assays. Cells infected with Ad-b-gal or Ad-myc-Parkin (multiplicity of
infection (MOI): 150) were treated with vehicle or 5mM 3-methyladenine (Sigma)
for 30min before dimethyl sulfoxide (DMSO; Sigma) or 25 mM FCCP (Sigma)
exposure. Cells with Rab7 knockdown were infected with Ad-mCherry-Parkin
(MOI: 150) and then re-transfected with control or Rab7 siRNA. Cells over-
expressing Ad-GFP or Ad-GFP-Rab5S34N (MOI: 75) plus Ad-myc-Parkin (MOI:
150) were treated with DMSO or 25 mM FCCP for 24 h. Cells with ESCRT protein
knockdowns were infected with Ad-mCherry-Parkin (MOI: 75) and then
re-transfected with control or ESCRT-speciﬁc siRNA for another 48 h. Cells were
then treated with DMSO or 25 mM FCCP for 24 h. In hypoxia cell death experi-
ments, cells were infected with Ad-mCherry-Parkin (MOI: 75) and Ad-GFP or
Ad-GFP-Rab5S34N (MOI:40), placed in hypoxic buffer and kept at normoxia or
hypoxia for 34 h as described above. To assess viability, cells were stained with
Yo-Pro-1 (1:1,000; Life Technologies), propidium iodide (1:3,000; Life Technolo-
gies) or with Po-Pro-3 (1:1,000; Life Technologies) plus Hoechst 33342 (invitrogen)
for 20min. Cell death was assessed as the number of Yo-Pro-1, propidium iodide
or Po-Pro-3-positive cells divided by total number of Hoechst 33342-positive cells
as described64.
Immunoﬂuorescence. Cells were ﬁxed with 4% paraformaldehyde (Ted Pella Inc.)
in Dulbecco’s PBS without calcium chloride and magnesium chloride (PBS)
(Gibco, 14200-075), permeabilized with 0.2% Triton X-100 or 0.1% saponin (for
Lamp2 staining) in PBS and blocked in 5% normal goat serum. Myocytes were
blocked with 5% normal goat serum plus 0.2% Tween20 in PBS (PST). Cells were
incubated with primary antibodies (4 C, overnight) in PBS (MEFs) or PST
(myocytes), rinsed with PBS, incubated with secondary antibodies (37 C, 1 h) and
counter-stained with Hoechst 33342. Fluorescence images were captured using a
Carl Zeiss Axio Observer Z1 ﬁtted with a motorized Z-stage with a  63 Plan-
Apochromat (oil immersion) objective. Z-stacks of red and green ﬂuorescence
separated by 0.6 mm along the z axis were acquired with an ApoTome using a high-
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14050 ARTICLE
NATURE COMMUNICATIONS | 8:14050 | DOI: 10.1038/ncomms14050 |www.nature.com/naturecommunications 13
resolution AxioCam MRm digital camera and Zeiss AxioVision 4.8 software (Carl
Zeiss). Mitochondrial clearance was scored on a per cell basis. Mitochondrial
clearance progresses through a well-documented series of steps including nuclear
aggregation before complete removal65; thus, cells displaying nuclear aggregation
or lack of mitochondria were scored as ‘cleared.’ Endosomal and autophagic
vesicles in cells were quantiﬁed by counting the number of distinct, visible puncta
in a maximal projection image of each cell. Co-localization was determined by
manually scoring the number of puncta on single Z-stack slices that had clear
signal in both red and green image channels. All scoring of morphology and
puncta counts were scored unblinded with respect to sample identity. Confocal
images were captured on a Leica SPE II (Leica) inverted confocal microscope
equipped with 405, 488, 561 and 637 nm lasers, with 0.25 mm step size between
optical sections. Assessment of mitochondrial depolarization was performed
by transfecting cells with HA-Parkin and GFP-Rab5, treating with DMSO
or 25mM FCCP for 4 h and adding MitoTracker Red CMXROS (Thermo Fisher
Scientiﬁc, M7512) at a ﬁnal concentration of 250 nM for 20min before ﬁxation and
subsequent staining.
WB analysis. Cells were lysed in 50mM Tris-HCl, 150mM NaCl, 1mM
EGTA, 1mM EDTA, 1% Triton X-100 and Complete protease inhibitor cocktail
(Roche). Lysates were cleared by centrifugation at 20,000 g for 20min at 4 C.
Proteins were separated on NuPAGE Bis-Tris gels (Life Technologies) and
transferred to nitrocellulose membranes. Membranes were incubated with the
indicated antibodies and imaged with a Bio-Rad ChemiDoc XRSþ imager.
Band densitometry quantiﬁcation was performed using the software
Quantity One (Bio-Rad). Unprocessed original scans of blots are shown in
Supplementary Fig. 11.
Isolation of the heavy membrane fraction. Atg5 / MEFs were infected
with mCherry-Parkin virus (MOI: 75) and were treated with DMSO or 25 mM
FCCP for 4 h. Cells were collected using a cell scraper and incubated in isolation
buffer (220mM mannitol, 70mM sucrose, 1mM EDTA and 10mM HEPES at
7.4 pH) for 45min on ice. Cells were homogenized using an Eppendorf pestle
and centrifuged for 10min at 1,000 g to pellet unbroken cells. The supernatant was
collected and centrifuged for 15min at 14,000 g to collect the heavy membrane
fraction. After removal of the supernatant, the remaining pellet was resuspended
in isolation buffer and separated by SDS–PAGE.
Real-time quantitative PCR. RNA was extracted using the RNeasy Mini Kit
(Qiagen) and reverse transcribed to complementary DNA with the QuantiTect
Reverse Transcription Kit (Qiagen) according to the manufacturer’s instructions.
Quantitative PCR was performed with standard TaqMan primers and TaqMan
Universal Mastermix II (Applied Biosystems) on a 7500 Fast RealTime PCR system
(Applied Biosystems). Fold difference was calculated by the comparative
CT(2DDCT) method against Gapdh or 18 s66. Primers used targeted mouse
Rab5a (Integrated DNA Technologies; assay ID: Mm.PT.56a.10093885),
Rab5b (Integrated DNA Technologies; assay ID: Mm.PT.56a.29871709)
and Rab5c (Integrated DNA Technologies; assay ID: Mm.PT.56a.28760014).
Male and female WT C57BL/6 mice, age 8–12 weeks, were used for quantitative
PCR of hearts. All animal protocols were in accordance with institutional
guidelines and approved by the Institutional Animal Care and Use Committee
of the University of California, San Diego.
Electron microscopy. For the correlated light and electron microscopy, cells
were plated on gridded MatTek dishes (MatTek Corporation) and transfected
with GFP-Rab5, nanobody against GFP (VHH)-APEX2 (ref. 67), HA-Parkin and
mPlum-mito-3 using Fugene 6 (Promega Inc.) according to the manufacturer’s
instructions. Cells were treated with 25 mM FCCP or DMSO for 4 h, then ﬁxed
in 2.5% glutaraldehyde in 0.1M cacodylate buffer pH 7.4 for 1 h on ice and imaged
on a Leica SPE II (Leica) inverted confocal microscope. For VHH-APEX2, the
diaminobenzidine staining was performed as previously described24. Cells were
postﬁxed in 1% osmium tetroxide for 30min on ice. After several washes in
cold double distilled water, cells were dehydrated in a cold graded ethanol series
(20, 50, 70, 90 and 100%) 3min each on ice, then washed in room temperature
100% ethanol and embedded in Durcupan ACM resin (Electron Microscopy
Sciences, Hatﬁeld, PA). Sections were cut using a diamond knife (Diatome) at a
thickness between 200 and 300 nm for electron tomography and collected on
LuxFilm grids (Luxel Corporation). Colloidal gold particles (5 and 10 nm diameter)
were deposited on each side of the sections to serve as ﬁducial markers.
EM data were obtained using FEI Titan high base microscope operated at
300 kV; micrographs were produced using a 4 k 4 k Gatan charge-coupled
device camera (US4000). For each section, montages of the cell of interest
were acquired using the SerialEM software package. The set of two-dimensional
EM maps of the cell under scrutiny was correlated with the 3D light microscopy
stack allowing a global registration of the two modalities. This enabled the
EM tracking of puncta representing the co-localization of the GFP-Rab5 and
the mitochondrial signal in the light microscopy volume. This was accomplished
using an in-house software allowing side-by-side comparison of multiple
views across different microscopy modalities and establishing an optimal
3D registration. For tomography, double-tilt series were collected using the
SerialEM package. For each series, the sample was tilted from  60 to
þ 60 degrees, every 0.5 degree. Tomograms were generated using iterative
reconstruction procedure68. To analyse larger volumes consecutive sections
were reconstructed serially. The 3D reconstruction modelling was done with
the IMOD tomography software package69.
Statistical analysis. All experiments were independently repeated in the labora-
tory. Data were collected from experiments performed in at least triplicate and
expressed as mean±s.e.m. No statistical method was used to predetermine sample
size. Differences between groups were assayed using repeated-measure analysis of
variance tests with Dunnett’s post-hoc test, as determined by the data type. The data
meet the assumptions of this test, and variances are similar between the groups that
are being compared. Differences were considered to be signiﬁcant when Po0.05.
Analyses were done unblinded with respect to sample identity. Data were excluded
if transfection efﬁciency was o40% or if cells appeared unhealthy in control
conditions. Panels in Figs 1a,c,d,g and 2a,b,g, Figs 5a,d and 6a,c,f,h,j, Figs 7c,g and
8a,f, and Supplementary Figs 1a,b,c,e, 2a,d, 3a,c,e, 4a,d,g, 8a,c,e,f, 9a,c,e and 10d,f
show representative images from experiments that were repeated at least three
times.
Data availability. All relevant data are available from the authors. All
correlated electron microscopy image data, tomograms, segmentations and
full-resolution movies can be accessed for downloading in the Cell Centered
Database and Cell Image Library (http://www.cellimagelibrary.org/images?k=
project_20381&simple_search=Search) under the project ID 20381.
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